Tiny patients, big challenge: new malaria pill for newborns
NCT ID NCT04300309
Summary
This study tested a new, easy-to-swallow tablet version of a common malaria medicine (artemether-lumefantrine) for the smallest patients: babies and newborns weighing less than 11 pounds. The goal was to see if the right amount of medicine gets into their bodies, if it's safe for them, and if it effectively clears the malaria parasite. The study included two groups of very young infants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Novartis Investigative Site
Nanoro, Burkina Faso
-
Novartis Investigative Site
Ouagadougou, Burkina Faso
-
Novartis Investigative Site
Kisantu, Bas Kongo, Democratic Republic of the Congo
Conditions
Explore the condition pages connected to this study.